Search

everythinglearnresearchcommunity

for

Search:↓

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

Exclamation mark hairs suggest early scalp disease, while white dots indicate it's chronic.

The patient with both scarring and non-scarring hair loss showed complex immune reactions and improved with steroid treatment.

CCCA may be caused by both hair traction and an immune response.

Hair loss in Lichen Planopilaris is caused by immune system issues damaging hair follicles and stem cells.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Damage to hair follicle stem cells may cause permanent hair loss and scarring in PCA.

Hair loss in African American women, caused by hair care, genetics, and environment, needs more research for better treatment.

CCCA and LPP may be related hair loss conditions influenced by genetics and environment, needing early treatment.

Early detection of Graham-Little-Piccardi-Lasseur syndrome is key for better management.

Trichoscopy is a key method for dermatologists to quickly and effectively diagnose hair and scalp conditions.

The updated SALT II tool offers a more precise way to measure scalp hair loss.

Trichoscopy helps diagnose hair and scalp disorders in dark-skinned people by identifying unique patterns.

Pseudopelade of Brocq is a unique hair loss condition, but its cause and development are still not fully understood.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

People with lichen planopilaris often have seborrheic dermatitis, which can delay the diagnosis of lichen planopilaris.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

A specific drug can help treat Lichen Planopilaris, a condition causing permanent hair loss.

Some people experienced hair loss after mesotherapy treatments for hair loss.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

The document concludes that using specific tools and tests is essential for identifying the cause of hair loss and deciding on the right treatment.

Non-ablative and ablative fractional lasers helped hair growth in some cases without major side effects, but didn't work for all hair disorders.

New LPP subtype affects vellus hairs, mimics AGA, and needs biopsy for diagnosis.

Transverse sections are better for non-scarring hair loss, vertical sections are better for lichen planopilaris, and either method works for other scarring hair loss types.

More research is needed to understand hair and scalp disorders in people with skin of color.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Lichen planopilaris is a rare, chronic condition causing hair loss, mainly in middle-aged women, and early treatment is important to prevent permanent baldness.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Trichoscopy is good for diagnosing and monitoring hair and scalp problems in children but needs more research for certain conditions.

Certain scalp patterns can indicate the severity and activity of hair loss in Turkish alopecia patients.